Full Text View
Tabular View
No Study Results Posted
Related Studies
Secondary Prevention of Osteoporosis
This study has been completed.
Study NCT00421343   Information provided by National Institute on Aging (NIA)
First Received: January 10, 2007   Last Updated: August 28, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Osteoporosis
More general conditions related to this trial
Bone Diseases
Bone Diseases, Metabolic
Musculoskeletal Diseases
Interventions listed in this trial
alendronate with cholecalciferol
Falls prevention measures
Additional drug interventions recognized in this trial
Alendronate
Calcium Carbonate
Cholecalciferol
More general drug interventions related to this trial
Antacids
Bone Density Conservation Agents
Growth Substances
Micronutrients
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Vitamins
Sponsors listed in this trial
National Institute on Aging (NIA)
Merck
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services